Blog
RSS FeedPosted by Michael Wonder on 16 Apr 2020
Can the world find a good COVID-19 vaccine quickly enough?
16 April 2020 - And can it mass produce it fairly if it does? ...
Posted by Michael Wonder on 16 Apr 2020
Meeting highlights from ICMRA global regulatory workshop on COVID-19 observational studies and real world data
16 April 2020 - Observational studies of data generated in clinical practice in the context of COVID-19 can contribute to the ...
Posted by Michael Wonder on 16 Apr 2020
Biopharmaceutical sector waging war on COVID-19 with over 60 vaccines and medicines
16 April 2020 - The World Health Organization has declared that COVID-19 is a pandemic and 144 countries across the ...
Posted by Michael Wonder on 15 Apr 2020
Vaccine development becomes reality TV. Can it make viewers rethink pharma?
14 April 2020 - The pharmaceutical industry’s response to the novel coronavirus may not rescue its ailing reputation. But it ...
Posted by Michael Wonder on 15 Apr 2020
Sanofi and GSK to join forces in unprecedented vaccine collaboration to fight COVID-19
14 April 2020 - Candidate vaccine expected to enter clinical trials in the second half of 2020 and, if successful, to ...
Posted by Michael Wonder on 15 Apr 2020
COVID-19: NZ should develop vaccine programme, say scientists
15 April 2020 - New Zealand needs to act now to make sure it's not left behind when a successful ...
Posted by Michael Wonder on 15 Apr 2020
Product specific guidances for chloroquine phosphate and hydroxychloroquine sulphate
13 April 2020 - The FDA plays a critical role in protecting the United States from threats including emerging infectious ...
Posted by Michael Wonder on 14 Apr 2020
Vaccine development is a case of 'market failure'
13 April 2020 - Reliance on the private market to develop vaccines has failed, leaving us vulnerable to pandemics such as ...
Posted by Michael Wonder on 14 Apr 2020
Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review
13 April 2020 - The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 ...
Posted by Michael Wonder on 14 Apr 2020
Public statement for collaboration on COVID-19 vaccine development
13 April 2020 - On 31 December 2019, WHO was informed of a cluster of cases of pneumonia of unknown cause ...
Posted by Michael Wonder on 14 Apr 2020
COVID-19: Ebola drug leads treatment race
13 April 2020 - A failed Ebola drug is emerging as the treatment of choice for COVID-19 after Australian scientists ...
Posted by Michael Wonder on 14 Apr 2020
COVID-19: world needs a global approach to fight: Bill Gates
12 April 2020 - Over the past few weeks, I’ve spoken to dozens of experts about COVID-19, and there’s clear ...
Posted by Michael Wonder on 08 Apr 2020
Pharmaceutical profits and public health are not incompatible
8 April 2020 - We need the capital and creativity of the private sector to take on the coronavirus. ...
Posted by Michael Wonder on 08 Apr 2020
Cows come home for CSL in COVID-19 vaccine battle
8 April 2020 - It sounds like a pitch for a sci-fi thriller — using genetically modified cows to fight ...
Posted by Michael Wonder on 07 Apr 2020
Global plasma leaders collaborate to accelerate development of potential COVID-19 hyperimmune therapy
6 April 2020 - Partnership brings together world-leading plasma companies to focus on developing and delivering a hyperimmune immunoglobulin in the ...